Respinor

About

Respinor AS is a Norwegian medical technology company developing non-invasive ultrasound-based monitoring solutions for diaphragm function. Founded in 2015 with 9 employees.

Product

DXT

DXT is a novel, non-invasive ultrasound device for diaphragm monitoring. Key features:

• Non-invasive ultrasound-based technology
• Accurate and continuous diaphragm monitoring
• Enables early detection of diaphragm dysfunction
• Designed for critical care settings
• Successfully validated in clinical studies on mechanically ventilated patients

Clinical Need

Diaphragm dysfunction in critically ill patients is associated with:

• Increased mortality in ICU
• Prolonged mechanical ventilation
• Difficult weaning from ventilators
• Increased healthcare costs

Currently, monitoring diaphragm function in ICU patients is challenging. DXT addresses this with a non-invasive approach that can detect dysfunction early.

Market

Critical care monitoring represents a significant market. Diaphragm ultrasound is an emerging standard of care, and a dedicated device for continuous monitoring could address a growing clinical need as ICU awareness of diaphragm dysfunction increases.